<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

News and Stories


Research    Patient Care    Cancer    CU Anschutz 360 Podcast    lymphoma

Why Is CAR T-Cell Therapy ‘One of the Most Phenomenal Advances in Science’?

This episode of CU Anschutz 360 focuses on a promising breakthrough therapy for patients with large B-cell lymphoma, an aggressive subtype of the disease. The clinical trial was led by Manali Kamdar, MD, clinical director of the lymphoma program in the Division of Hematology at the University of Colorado School of Medicine.

Author Chris Casey | Publish Date August 16, 2022
Full Story